Expert Reflects on Immunotherapy’s Milestone Impact in NSCLC, and Questions That Still Remain – Targeted Oncology
Targeted Oncology |
Expert Reflects on Immunotherapy’s Milestone Impact in NSCLC, and Questions That Still Remain
Targeted Oncology Immunotherapy has made a significant impact in the field of non–small cell lung cancer (NSCLC). However, as more research unravels, investigators are unsure which set of combinations will have the most positive effect on their patients with advanced … |
Targeted Oncology |
Expert Reflects on Immunotherapy’s Milestone Impact in NSCLC, and Questions That Still Remain
Targeted Oncology Immunotherapy has made a significant impact in the field of non–small cell lung cancer (NSCLC). However, as more research unravels, investigators are unsure which set of combinations will have the most positive effect on their patients with advanced … |
OncLive |
Expert Discusses Immunotherapy Advances in Head and Neck Cancer
OncLive “Regarding the responsiveness of immunotherapy versus the responsiveness of standard-of-care chemotherapy, platinum-based doublets with cetuximab have response rates of 40% and PD-1 inhibitors have response rates of 18%. For symptomatic patients … |
Genetic Engineering & Biotechnology News |
Scaffold Delivers ‘Atomic Bomb’ CAR–T Tx in Preclinical Solid Tumors
MedPage Today A tiny implantable biopolymer scaffold that delivers rapidly-expanding densities of anti-tumor chimeric antigen receptor (CAR) T-cells as well as immune-boosting beta-agonists to either the surface of a tumor or to the resection site in the preclinical … Anticancer T Cells Occupy Biopolymer Camp Sites in the Solid Tumor WildGenetic Engineering & Biotechnology News Fred Hutch Study: Novel immunotherapy tech made tumors shrink, a good sign for future treatmentsGeekWire Dissolving implant could bring immunotherapy to solid tumorsFred Hutch News Service |
Daily Mail |
Cellular Dynamics Adds to Stem Cell Work With Harvard Institute
Xconomy Cellular Dynamics International, a Madison, WI-based manufacturer of human cells, recently signed a collaboration agreement with the Harvard Stem Cell Institute that’s aimed at making greater quantities of stem cells available to researchers at the … Stem cells from our own bodies could cure MS and diabetesDaily Mail Allied Physical Medicine and R3 Stem Cell partner to offer stem cell procedures — 4 detailsBecker’s Orthopedic & Spine Neurological Regenerative Medicine – Unlocking the Potential of Stem Cells in the Olfactory SystemSelectScience DailyHover –Medgadget (blog) –Deccan Herald all 12 news articles » |